Motixafortide alone and in combination with natalizumab can support the collection of the large number of stem cells required ...
Key Highlights Motixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies 90% (9 of 10) of ...
Gamida Cell has scored an expansion for Omisirge, with the FDA endorsing the stem cell-based therapy to treat severe aplastic ...
Kylie Jenner disclosed she used stem cell therapy to treat chronic back pain after conventional treatments failed. Here's how ...
Stocktwits on MSN
Exicure stock soars 40% after stem cell drug helps most patients hit phase 2 goal — traders call it 'cheap' at current levels
Phase 2 data showed rapid increases in CD34+ stem cells, allowing same-day dosing and collection. ・Daratumumab-treated ...
MedPage Today on MSN
Gene Therapy-Induced CAR T Cells for Myeloma Could Alter Treatment Landscape
ORLANDO -- A gene therapy that could transform CAR T-cell treatment achieved rapid and potentially durable measurable ...
Updated Data from 31 Adult and Adolescent SCD Patients Treated with risto-cel (Formerly BEAM-101) Show Mean Hemoglobin F (HbF) Induction of ...
A study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers ...
A new study shows that giving the chemotherapy drug cyclophosphamide after allogeneic hematopoietic cell transplantation, a curative treatment for common types of blood cancer, can make the procedure ...
News-Medical.Net on MSN
Challenges and opportunities in delivering gene therapies for sickle cell disease and beta thalassemia
The first study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia ...
We spoke with representatives from Anthony Nolan and eXmoor to discuss both their collaboration and the importance of ethical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback